Hypoglycemia in pregnancies complicated by diabetes mellitus: maternal and fetal considerations.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to E A Reece.
Explore the source record for details and available documents.
Diabetes mellitus with its resulting derangement of various metabolic fuels, carbohydrates, amino acids, lipids, and ketones has the potential to adversely affect the developing fetus. Therefore, strict glycemic control in pregnancy has become the standard of care in modern obstetrics. A considerable amount of research has been undertaken into the metabolic changes that occur during pregnancy in both women with insulin-dependent diabetes and gestational diabetes. This paper will review current research in normal and diabetic pregnancies both in the fasting and fed states as well as during episodes of hypoglycemia. In normal pregnancy insulin secretion increases throughout gestation whereas peripheral insulin sensitivity is decreased. Fasting levels of plasma glucose are reduced by approximately 10 per cent during the first trimester. Maternal amino acid levels are also reduced in normal pregnancy, although cholesterol and triglyceride levels are increased, most dramatically in the second trimester. As gestation advances, progressively increasing amounts of insulin antagonistic hormones are secreted by the placenta. This leads to gestational diabetes in 2 to 3 per cent of women who exhibit hyperglycemia despite an increased insulin response to oral glucose as well as an increased insulin/glucagon ratio. In insulin dependent diabetes mellitus, the insulin-deficient state results in fasting and postprandial hyperaminoacidemia, hyperlipidemia, and hyperglycemia. These metabolic changes and the resulting hyperglycemic milieu can lead to fetal macrosomia that will result in maternal and fetal morbidity. Therefore, normalization of these fuels with the use of intensive insulin regimens is the goal of therapy during pregnancy.
The utility of Doppler ultrasonography as a means of assessing potential alterations of vascular resistance prior to fetal or maternal compromise is very attractive. We investigated this relationship by prospectively performing Doppler studies of the fetal umbilical artery in 56 diabetic patients, 14 of whom had varying degrees of vascular complications. When regression curves were established for the S/D ratio, the Pourcelot index, and the resistance index of the fetal umbilical artery, the mean Doppler values were higher in diabetic patients with vasculopathy than in nondiabetic control patients or in diabetic patients without vasculopathy. The third trimester S/D ratio was greater than 3.0 in almost 50% of patients with vasculopathy. A tendency toward adverse outcomes was observed at S/D ratios approaching 4.0. Statistically significant correlations were found between elevated Doppler indices and maternal vasculopathy associated with hypertension and worsening renal insufficiency. Intrauterine growth retardation and neonatal metabolic complications were also significantly correlated with elevated Doppler indices. There was, however, no correlation between Doppler indices and glucose values, although most were within a euglycemic range. The aforementioned data indicate an increased resistance circuit among diabetics with vasculopathy, which may reflect a relative reduction in basal uteroplacental blood flow and the need for cautious interpretation of Doppler indices in these patients.
OBJECTIVE: To determine the relation between normal human fetal growth and the levels of insulin-like growth factors (IGF-I, IGF-II), their receptors, and IGF binding protein-3 (IGFBP-3) in both the maternal and fetal compartments. METHODS: Serum samples were obtained from normal pregnant women (n = 52) and their fetuses (n = 32) via funipuncture at 21-34 weeks' gestation (mean 29 +/- 4.3) and from term neonates (n = 20) between 38-41 weeks (mean 39 +/- 0.9). Neonates were divided into two groups: the "large" group, whose weights were above the mean for gestational age, and the "small" group, whose weights were below the mean. Aliquots of amniotic fluid (AF) and serum samples were analyzed for levels of IGF-I, IGF-II, and IGFBP-3. Type 1 IGF receptors were assayed from placental extracts of first-trimester elective abortions and from term deliveries. RESULTS: Fetal IGF-I serum levels remained stable throughout most of pregnancy until 34 weeks' gestation (56 +/- 30 ng/mL). Thereafter, IGF-I increased significantly until term (79 +/- 8 ng/mL) (P < .05). Fetal IGF-II levels were relatively unchanged from 23 weeks to term except for a significant increase at 34 weeks. Fetal serum levels of IGFBP-3 averaged 0.8 +/- 0.05 microgram/mL up to 30 weeks' gestation and then increased slightly toward term, at 0.96 +/- 0.05 micrograms/mL. At term, the levels of IGF-I and IGF-II in the AF were not different from the levels in the neonatal serum, but were lower (P < .005) than those in maternal blood. All placental tissue obtained from first-trimester terminations of pregnancy assayed positive for IGF type 1 receptors. There was a direct correlation between neonatal weight and the levels of IGF-I (P < .02), but not with the levels of IGF-II. There were no significant correlations between newborn weights and IGFBP-3, or maternal serum levels of IGF-I and IGF-II. Amniotic fluid IGF-I and IGF-II levels were almost similar to fetal serum levels. CONCLUSION: These data demonstrate the presence of type 1 receptors and the bioavailability of IGF-I, IGF-II, and IGFBP-3 throughout pregnancy. Insulin-like growth factor-I is shown to be adjunctively and directly associated with fetal size in normal pregnancies. The precise role that IGFs play in deviant fetal growth or whether IGFs can be used to treat reduced fetal growth remains unknown and awaits further investigation.
Explore the source record for details and available documents.
Congenital malformations affect approximately 2-3% of all live births every year. Several of these are associated with in-utero fetal demise or may account for significant neonatal morbidity and mortality. Therefore, it is important that, when possible, congenital anomalies are diagnosed during the antenatal period to allow adequate counseling of the mother and to permit preparation of the neonatal care team to optimize the outcome. The role of ultrasound in perinatal medicine has expanded over the past two decades. Previously, B-mode sonography allowed for the detection of multiple gestations, fetal biometry, and basic antenatal diagnosis of congenital anomalies. The technology has since rapidly advanced to the point that even subtle abnormalities are amenable to antenatal diagnosis. Perinatal medicine has advanced concurrently with these technological breakthroughs, and as a result, the possibilities for in-utero therapy and potential surgery have markedly improved. This article reviews the types and incidences of the various anomalies that are detectable by antenatal ultrasonography using a systematic approach; highlights the prenatal diagnostic and therapeutic strategies; discusses the obstetrics and medical management of pregnancies complicated by these conditions, and presents the neonatal prognosis and the recurrence risks for subsequent pregnancies.
The objective of this study was to examine the retinal and pregnancy outcomes of pregnancies complicated by advanced diabetic retinopathy. Twenty pregnancies complicated by advanced diabetic retinopathy were included in this retrospective study. The data were analyzed to determine trends in perinatal outcome and to document the ophthalmologic performance. Ophthalmologic management included frequent funduscopic examinations by ophthalmologists of the Yale Retina Center. Among the 20 pregnancies, spontaneous abortion occurred in 2 (10%) and stillbirth in 1 (5%); the remaining 17 (85%) pregnancies culminated in live births at a mean gestational age of 36 weeks (+/- 2.3 SD), with a mean birth weight of 2,620 g (+/- 834 SD). The perinatal survival rate was 94%. Photocoagulation therapy was necessary prior to pregnancy in 45%, during pregnancy in 60% and postpartum in 65%. No pregnancies were terminated because of progressive visual changes that did not respond to photocoagulation therapy. Retinal status should not preclude pregnancy since contemporary methods of management can result in satisfactory retinal and pregnancy outcomes even in the presence of advanced diabetic microvascular disease.
Diabetes mellitus is a commonly encountered medical complication of pregnancy that affects more than 100,000 pregnancies annually. The discovery of insulin and numerous scientific advances, including both fetal heart rate and glucose monitoring, dramatically improved the outlook for women with diabetes and their offspring. However, despite these recent advances, women with diabetes and their infants still remain at higher risk for a number of complications. Pregnancy has frequently been characterized as having a diabetogenic effect on normal carbohydrate metabolism, as evidenced by hyperglycemia and hyperinsulinemia in response to feeding. This leads to gestational diabetes in 2% to 3% of women and a worsened metabolic state in women with insulin-dependent diabetes mellitus. Since the availability of nutrients for the fetus is primarily dependent on the maternal metabolic state, these aberrations in fuel metabolism are believed to result in a host of perinatal complications, including diabetic embryopathy. In fact, the frequency of congenital anomalies is increased among infants of women with diabetes; they are responsible for approximately 40% of all perinatal deaths. Recent evidence suggests that normalization of blood glucose levels coupled with contemporary management strategies can reduce the frequency of congenital anomalies as well as improve maternal and neonatal outcomes. However, to impact on the congenital anomalies, euglycemia must begin in the preconceptual period and continue throughout organogenesis. Preconception counseling and intensive therapy regimens remain the focus of management programs targeted at women with diabetes.
OBJECTIVE: To explore the feasibility of using a newly devised needle endoscope to conduct transabdominal first-trimester endoscopy for both embryonic visualization and blood sampling. METHODS: Following informed consent, 12 patients at 8-12 weeks' gestation undergoing first-trimester termination were invited to participate in this study. Transabdominal needle embryofetoscopy was also performed in one continuing pregnancy. A specially designed 16-gauge, double-barrel instrument sheath equipped with 0.8-mm fiberoptic endoscope and a customized 27-gauge heparinized needle were passed transabdominally under ultrasound guidance through the uterine wall and into the exocoelomic space. RESULTS: Using first-trimester transabdominal needle embryofetoscopy, we were able to identify the normal anatomical landmarks of the embryo and were also able to gain access to the embryonic circulation by advancing the 27-gauge needle into the umbilical vessels. In addition, we were able to infuse indigo carmine dye into the fetal circulation of three subjects. Needle embryofetoscopy was also used in a continuing pregnancy for prenatal diagnosis. CONCLUSION: Our experience establishes the feasibility of first-trimester transabdominal needle embryofetoscopy for embryonic visualization and access to the circulation. This new development is expected to serve as a basis for further studies attempting to diagnose and treat congenital diseases in early pregnancy.
OBJECTIVE: We evaluated the influence of forceps delivery on cognitive development of preschool children. STUDY DESIGN: A cohort of 3413 children who were born at the Kaiser Permanente Medical Center in Oakland, California, were selected at age 5 for intelligence quotient testing with the Peabody Picture Vocabulary Test and the Raven Coloured Progressive Matrices. Data were analyzed by means of the Student t test to compare mean intelligence quotient scores of intervention modes of delivery with spontaneous delivery. RESULTS: No significant difference in intelligence quotient was seen in 1192 children delivered by forceps (114 midforceps) compared with 1499 who were delivered spontaneously. CONCLUSION: The association of forceps delivery with adverse cognitive development cannot be supported.
A fiber-enriched diabetic diet that contained a modest increase in dietary fiber and a commercially available fiber supplement was studied in pregnant diabetic women for its potential glucose-lowering effects. Noninsulin-requiring gestational diabetic patients were placed on a fiber-enriched diet of increasing fiber content starting with 40 gm and eventually achieving a maximum tolerable dose of 80 gm of fiber per day. Initial pilot study demonstrated that patients could not tolerate more than 40 gm of fiber-rich food. Therefore additional fiber was administered via commercially available high-fiber drink. Satisfactory patient acceptance and compliance were achieved using this method. The response curve was flat with no lowering of blood glucose with increasing dietary fiber content. Furthermore, when the group receiving the moderate-fiber dose (40 to 60 gm), the high-fiber dose (70 to 80 gm), and a third group on an American Diabetes Association recommended diet (20 gm or less of fiber) were compared, no significant difference was observed in the mean blood glucose and postprandial glucose levels. This pilot study demonstrates that high-fiber diets, although better tolerated by patients when administered in divided amounts, are not associated with a concomitant lowering of blood glucose levels in pregnant diabetic patients.
This study compared the course of lactation from days 2 to 84 postpartum in 33 women with insulin-dependent diabetes mellitus (IDDM); 33 women without diabetes selected by using gestational age of the infant, method of delivery, sex of the infant, and prior lactation experience as a means of ensuring similar patterns in factors known to influence success (control subjects); and 11 healthy reference subjects who delivered vaginally. Nutritionists visited the mothers on days 2, 3, 7, 14, 42, and 84 postpartum; obtained prenatal and perinatal medical information; and questioned the mothers on their breast-feeding experience. Women with IDDM were able to establish lactation despite postpartum separation from their infants, delays in the start of breast-feeding, reduced frequency of feeding, increased use of supplemental feedings, and the high rate of cesarean section. Clinicians must recognize the need to provide appropriate counseling so that mothers with IDDM will not be discouraged by problems with breast-feeding.
The incidence of congenital anomalies remains the major cause of morbidity and mortality among the offspring of diabetic women. Animal and human studies indicate that these malformations occur early in pregnancy and are influenced by the abnormal maternal metabolic milieu. This article reviews the recent advances in understanding the pathogenesis of diabetic embryopathy. A possible pathway to explain the various diabetic-related fuel aberration is presented.
Diabetes mellitus is a major medical complication of pregnancy and is associated with an increased risk of maternal and perinatal morbidity and mortality. Although recent advances have improved outcomes dramatically, the increased incidence of congenital malformations remains a significant problem. In the past, it was believed that pregnancy worsened microvascular complications, and women with vasculopathy were counseled to avoid or terminate pregnancies. Recent evidence suggests that normalization of blood glucose levels and current management strategies can lead to improved outcomes even in women with vasculopathy. Today, with the exception of coronary artery disease, women with diabetes may be counseled toward a more favorable outcome. This article discusses preconception planning and contemporary treatment methods.
OBJECTIVE: To assess the feasibility of gaining access to the embryonic-fetal circulation via first-trimester transcervical embryoscopy. METHODS: A fiberoptic endoscope with a 3.5-mm, wide-angle lens was passed transcervically through the chorion and into the exocoelomic cavity of women undergoing pregnancy termination. A 26-gauge heparinized needle was passed through the sideport of the endoscope and inserted into the blood vessels of the chorionic plate or umbilical cord to obtain blood samples. RESULTS: With a modified endoscope, we have been able to gain access into the embryonic-fetal circulation and obtain a small aliquot of blood in five of eight cases. CONCLUSIONS: Our experience establishes the feasibility of gaining access to the human embryonic-fetal circulation. This work is expected to serve as a basis for further studies of the diagnosis and treatment of congenital diseases in early pregnancy.
Thirty-four cases of fetal Dandy-Walker malformation recognized in utero with ultrasound between 16 and 37 weeks' gestation are reported. In each case a qualitative examination of the posterior fossa structures was performed, including the cerebellar hemispheres, cerebellar vermis, fourth ventricle and cisterna magna. In each case, the transverse cerebellar diameter and the depth of the cisterna magna were measured in a standard transcerebellar view of the fetal brain. The atrial width of the lateral ventricles was also assessed. The transverse cerebellar diameter was abnormal in 15 cases, the cisterna magna depth was abnormal in 33, and the atrial width was abnormal in 30. It is concluded that measurement of the transverse cerebellar diameter is unreliable in predicting fetal Dandy-Walker malformation. Measurements of the cisterna magna and atrium seem to be more valuable, although the real sensitivity remains unclear. In pregnancies at risk for fetal Dandy-Walker malformation, the sonographic examination should not be limited to the cerebral ventricles and transcerebellar view but should include a detailed evaluation of all the different anatomical components of the posterior fossa, especially the fourth ventricle and inferior cerebellar vermis.
Advancing technology has made the fetus and its environment even more accessible to prenatal diagnosis and treatment. The current approach to prenatal diagnosis relies mainly on the use of high-resolution ultrasonography. However, as attempts are made to conduct antenatal diagnoses earlier in gestation, the limits of ultrasonography are approached. Embryoscopy allows for direct visualization of the first-trimester fetus with a fiberoptic endoscope. A customized side channel enables the operator to pass a variety of diagnostic tools and gain access into the fetal circulation. The further development and refinement of this technology are expected to change early prenatal diagnosis and treatment considerably. The potential contribution of this technique to perinatal medicine is readily apparent when it is placed in historic context. Undoubtedly, many ethical, legal, and regulatory questions will have to be addressed before the full potential of embryoscopy is realized. The responsibility for the judicious use of this powerful technology for prenatal intervention will have to be shared by the scientific community and a well-informed public.
OBJECTIVE: We attempted to compare the use of low-dose heparin with a standard dose of 40 mg prednisone daily (both plus low-dose aspirin) for treatment of pregnant women with antiphospholipid antibody-associated recurrent fetal loss with respect to maternal and perinatal morbidity and efficacy in prevention of fetal death. STUDY DESIGN: A multicenter randomized trial included 20 patients. Generalizability of results from randomized patients was evaluated by means of additional data from 13 women refusing and 12 women ineligible for randomization. Data from study groups were compared with Fisher's exact test, and generalizability was evaluated with a chi 2 test for trend. RESULTS: Live birth rates were the same (75%) with either treatment, but "serious" maternal morbidity and the frequency of preterm delivery were significantly higher among women randomly assigned to prednisone (p = 0.02 vs p = 0.006). Preterm delivery among prednisone-treated women was usually associated with premature rupture of the membranes or preeclampsia. These results could be generalized to the other groups of women ascertained during the course of the study. CONCLUSIONS: Low-dose heparin should be preferred to prednisone when treatment is indicated for high-risk pregnant women with antiphospholipid antibodies.